FDA Clearance Tracker · P090016-S067
Belotero Balance Dermal Filler; Belotero Balance (+) Lidocaine
Last checked: Nov 20, 2026Latest source record: May 3, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 3, 2026
Approved
Time to decision
249 days
Received Aug 27, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P090016-S067
- Device name
- Belotero Balance Dermal Filler; Belotero Balance (+) Lidocaine
- Applicant
- Merz North America, Inc.
- Applicant location
- Franksville, WI
- Received
- Aug 27, 2025
- Decided
- May 3, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P090016
Device type
- Device type
- Implant, dermal, for aesthetic use (LMH)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for the use of sodium hyaluronate raw material manufactured at a new supplier production line
Source documents
Other decisions for Merz North America, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250016 · Decided Jul 9, 2026 · 387 days after receipt
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.